Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Guido Jenster

Professor Experimental Urological Oncology

Erasmus MC

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

50%

Tissue Engineering

30%

Cancer Biology

40%

Prostate Cancer

40%

Urology

30%

Cell Culture Techniques

20%

Xenograft Models

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Elucidating Extracellular Vesicle Isolation Kinetics via an Integrated Off-Stoichiometry Thiol-Ene and Cyclic Olefin Copolymer Microfluidic Device

Article Link

Year:

2024

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids

Article Link

Year:

2023

Site-specific analysis of ribosomal 2′O-methylation by quantitative reverse transcription PCR under low deoxynucleotide triphosphate concentrations

Article Link

Year:

2023

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer

Article Link

Year:

2023

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

Article Link

Year:

2022

Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort.

Article Link

Year:

2022

Identifying genes targeted by disease-associated non-coding SNPs with a protein knowledge graph.

Article Link

Year:

2022

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.

Article Link

Year:

2022

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer.

Article Link

Year:

2022

CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue.

Article Link

Year:

2022

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.

Article Link

Year:

2022

Collaborators11

Elena Martens-Uzunova

Erasmus University Rotterdam

NETHERLANDS

Job van Riet

NETHERLANDS

Caroline M Moore

University College London

UNITED KINGDOM

John W. M. Martens

NETHERLANDS

Kerri Beckmann

University of South Australia

AUSTRALIA

Martin van Royen

Assistant Professor

Erasmus MC

NETHERLANDS

Harmen van de Werken

Assistant Professor Computational Biology & Bioinformatics at the Department of Immunology

Erasmus MC

NETHERLANDS

Wytske M. van Weerden

Erasmus University Medical Center

NETHERLANDS

Cristina Marenghi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Peter van der Spek

Erasmus University Rotterdam

NETHERLANDS

Martijn Lolkema

Head of Department a.i.

Erasmus MC

NETHERLANDS

How do I reach out?

Meet Kite AI